In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.
In the UK, local authorities have agreed a partnership with specialist developer Prologis (NYSE: PLD) to support the next ...
The test could serve as an alternative in cervical cancer screening, cytology, according to a new study. Certain types of ...